Literature DB >> 30953817

RETRACTED: lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer.

Fuquan Jiang1, Wenqian Qi2, Yao Wang1, Weihua Wang1, Li Fan3.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief as unusual similarity between the background of various Western Blots have been detected post-publication. Also, quadrants within various FACS plots appear similar to each other in Figure 2E. Panels from Figures 2C,D, 4C,D and 6D,E appear similar to panels from Figures 1B,C, 2D,E, 3D,E and 5C,D of the article that Zhiliang Guo, Lanlan Li, Yu Gao, Xiaoyun Zhang and Min Cheng have published in the Artificial Cells, Nanomedicine, and Biotechnology 47 (2019) 2624-2633 https://doi.org/10.1080/21691401.2019.1629953. Although this article was published earlier than the other article, the Editor decided to retract this article given concerns about the reliability of the data.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Bladder cancer; JAK/STAT; LRP6; PEG10; Wnt/β-catenin; miR-134

Mesh:

Substances:

Year:  2019        PMID: 30953817     DOI: 10.1016/j.biopha.2019.108814

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  13 in total

1.  LncRNA CASC9 Suppressed the Apoptosis of Gastric Cancer Cells through Regulating BMI1.

Authors:  Jun Fang; Wei Chen; Xiang-Ling Meng
Journal:  Pathol Oncol Res       Date:  2019-10-22       Impact factor: 3.201

2.  LRP6 as a biomarker of poor prognosis of breast cancer.

Authors:  Yunke Zhang; Chengchang Shu; Yusufu Maimaiti; Shuntao Wang; Chong Lu; Jing Zhou
Journal:  Gland Surg       Date:  2021-08

3.  TMPO-AS1 promotes cell proliferation of thyroid cancer via sponging miR-498 to modulate TMPO.

Authors:  Zhenyu Li; Yun Feng; Zhen Zhang; Xiaozhong Cao; Xiubo Lu
Journal:  Cancer Cell Int       Date:  2020-07-08       Impact factor: 5.722

Review 4.  A Role for the WNT Co-Receptor LRP6 in Pathogenesis and Therapy of Epithelial Cancers.

Authors:  Jennifer Raisch; Anthony Côté-Biron; Nathalie Rivard
Journal:  Cancers (Basel)       Date:  2019-08-13       Impact factor: 6.639

5.  Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression.

Authors:  Deyao Wu; Tielong Zhang; Jie Wang; Jian Zhou; Huixing Pan; Ping Qu
Journal:  Aging (Albany NY)       Date:  2019-12-17       Impact factor: 5.682

6.  LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis.

Authors:  Dong Fu; Chunwen Lu; Xingzhou Qu; Peng Li; Kai Chen; Liancheng Shan; Xiaodong Zhu
Journal:  Aging (Albany NY)       Date:  2019-10-10       Impact factor: 5.682

7.  The long non‑coding RNA CASC7 inhibits growth and invasion of non‑small cell lung cancer cells through phosphatase and tensin homolog upregulation via sequestration of miR‑92a.

Authors:  Ling Chen; Xin Li; Chaojing Lu; Yue Zhao; Ji Zhu; Lixin Yang
Journal:  Int J Oncol       Date:  2020-06-02       Impact factor: 5.650

8.  LncRNA CARLo-7 facilitates proliferation, migration, invasion, and EMT of bladder cancer cells by regulating Wnt/β-catenin and JAK2/STAT3 signaling pathways.

Authors:  Houfeng Huang; Xinrong Fan; Xuebin Zhang; Yi Xie; Zhigang Ji
Journal:  Transl Androl Urol       Date:  2020-10

Review 9.  Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review.

Authors:  Rui Batista; Nuno Vinagre; Sara Meireles; João Vinagre; Hugo Prazeres; Ricardo Leão; Valdemar Máximo; Paula Soares
Journal:  Diagnostics (Basel)       Date:  2020-01-13

10.  lncRNA BCAR4 sponges miR‑370‑3p to promote bladder cancer progression via Wnt signaling.

Authors:  Rongkui Zhang; Jiping Wang; Er'na Jia; Jialiang Zhang; Nan Liu; Changliang Chi
Journal:  Int J Mol Med       Date:  2019-12-27       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.